share_log

Walgreens expands collaboration to tackle epinephrine shot shortage

路透社 ·  Jul 11, 2019 20:17
July 11 (Reuters) - Walgreens Boots Alliance Inc  said on Thursday it expanded its collaboration with Kaleo Inc, making the privately held company's epinephrine auto-injector available at the drugstore chain's pharmacies, as supply issues persist for the emergency allergy shots.
   Epinephrine auto-injector makers have been facing a shortage of the devices and the collaboration helps broaden access to Kaleo's treatment for patients with life-threatening allergies, as families prepare for back-to-school season.

(Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Maju
Samuel)
((saumya.joseph@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 2290; Reuters Messaging:
saumya.joseph.thomsonreuters.com@reuters.net)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment